WEITZMAN DEBORAH (CEO, Pharmaceutical Segment) sold 28.6% of their position (21.37K shares) of CARDINAL HEALTH INC on the open market
Open‑market sale worth $3.22M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/20/2025ACC: 0000721371-25-000101
Officer· CEO, Pharmaceutical Segment
Since Sep 2022
-21.37K
Net shares
Net seller
$3.22M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
21.37K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−21.37K
Price / share
$150.53
Trade value
$3.22M
% of position
28.6%
8/20/2025
74.80K→53.43K
Total
Net shares
−21.37K
Net value
-$3.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 8/20/2025 | S · Sale | −21.37K | $150.53 | $3.22M | 28.6% | 74.80K | 53.43K |
| Total | −21.37K | -$3.22M | ||||||
Derivative Transactions0
No derivative transactions reported